How Common Are the Anxiety Disorders in Old Age?

Prevalence and Correlates of Agoraphobia in Older Adults

“…The DSM-IV allows for the focus of the fear in agoraphobia to be on panic-like symptoms such as cardiac symptoms or loss of bladder control as opposed to full-blown panic attacks. 4 The overall prevalence of agoraphobia was found to decline with age, which is also consistent with previous studies showing a decline in phobias 1,11 and in other anxiety disorders 21 with advancing age. 6 However, the survey instrument used to diagnose agoraphobia in this study required that the subjects be fearful specifically of a "panic attack."…”

Prevalence and Correlates of Agoraphobia in Older Adults

“…The DSM-IV allows for the focus of the fear in agoraphobia to be on panic-like symptoms such as cardiac symptoms or loss of bladder control as opposed to full-blown panic attacks. 4 The overall prevalence of agoraphobia was found to decline with age, which is also consistent with previous studies showing a decline in phobias 1,11 and in other anxiety disorders 21 with advancing age. 6 However, the survey instrument used to diagnose agoraphobia in this study required that the subjects be fearful specifically of a "panic attack."…”

A Randomized, Double-Blinded, Clinical Trial on Effects of a Vitis vinifera Extract on Cognitive Function in Healthy Older Adults

“…Reduction of HARS score, associated with improvement of cognitive performance evaluated with MMSE and RBANS in subjects receiving supplementation with V. vinifera extract, confirms a relationship between reduction of cognition and potential state anxiety. Our data are according to previous research linking anxiety with cognitive impairment and confirm that even within normal limits, potential state of anxiety can be associated with poorer global cognitive functioning ( Manela et al, 1996 ; Beekman et al, 1998 ). People recruited for the study did not show baseline BDI or HARS score levels indicating a pathological state of depression or anxiety; this finding could explain the lack of effects of placebo supplementation in reducing both the scores.…”

Anxiety and Depressive Disorders in Older Primary Care Patients: Defining a Clinical Severity Gradient Corresponding to Differences in Health Status, Functioning, and Health Service Use

“…This finding is consistent with general population studies such as the National Comorbidity Survey in which 62% of patients with a lifetime diagnosis of generalized anxiety disorder had a major depressive disorder and 40% had dysthymia (Wittchen et al 1994). Other studies have reported that the prevalence of depression occurring in anxiety disorders in older adults ranges from 70-90% (Lindesay et al 1989;Manela et al 1996). Depression in older persons is less likely to be treated when it occurs in the context of significant symptoms of anxiety and is more likely to be inappropriately treated with benzodiazepines (Flint 1998;Bartels et al 1997).…”

Prevalence and Correlates of Agoraphobia in Older Adults

“…The DSM-IV allows for the focus of the fear in agoraphobia to be on panic-like symptoms such as cardiac symptoms or loss of bladder control as opposed to full-blown panic attacks. 4 The overall prevalence of agoraphobia was found to decline with age, which is also consistent with previous studies showing a decline in phobias 1,11 and in other anxiety disorders 21 with advancing age. 6 However, the survey instrument used to diagnose agoraphobia in this study required that the subjects be fearful specifically of a "panic attack."…”

A Randomized, Double-Blinded, Clinical Trial on Effects of a Vitis vinifera Extract on Cognitive Function in Healthy Older Adults

“…Reduction of HARS score, associated with improvement of cognitive performance evaluated with MMSE and RBANS in subjects receiving supplementation with V. vinifera extract, confirms a relationship between reduction of cognition and potential state anxiety. Our data are according to previous research linking anxiety with cognitive impairment and confirm that even within normal limits, potential state of anxiety can be associated with poorer global cognitive functioning ( Manela et al, 1996 ; Beekman et al, 1998 ). People recruited for the study did not show baseline BDI or HARS score levels indicating a pathological state of depression or anxiety; this finding could explain the lack of effects of placebo supplementation in reducing both the scores.…”

Anxiety and Depressive Disorders in Older Primary Care Patients: Defining a Clinical Severity Gradient Corresponding to Differences in Health Status, Functioning, and Health Service Use

“…This finding is consistent with general population studies such as the National Comorbidity Survey in which 62% of patients with a lifetime diagnosis of generalized anxiety disorder had a major depressive disorder and 40% had dysthymia (Wittchen et al 1994). Other studies have reported that the prevalence of depression occurring in anxiety disorders in older adults ranges from 70-90% (Lindesay et al 1989;Manela et al 1996). Depression in older persons is less likely to be treated when it occurs in the context of significant symptoms of anxiety and is more likely to be inappropriately treated with benzodiazepines (Flint 1998;Bartels et al 1997).…”

Prevalence and Correlates of Agoraphobia in Older Adults

“…The DSM-IV allows for the focus of the fear in agoraphobia to be on panic-like symptoms such as cardiac symptoms or loss of bladder control as opposed to full-blown panic attacks. 4 The overall prevalence of agoraphobia was found to decline with age, which is also consistent with previous studies showing a decline in phobias 1,11 and in other anxiety disorders 21 with advancing age. 6 However, the survey instrument used to diagnose agoraphobia in this study required that the subjects be fearful specifically of a "panic attack."…”

A Randomized, Double-Blinded, Clinical Trial on Effects of a Vitis vinifera Extract on Cognitive Function in Healthy Older Adults

“…Reduction of HARS score, associated with improvement of cognitive performance evaluated with MMSE and RBANS in subjects receiving supplementation with V. vinifera extract, confirms a relationship between reduction of cognition and potential state anxiety. Our data are according to previous research linking anxiety with cognitive impairment and confirm that even within normal limits, potential state of anxiety can be associated with poorer global cognitive functioning ( Manela et al, 1996 ; Beekman et al, 1998 ). People recruited for the study did not show baseline BDI or HARS score levels indicating a pathological state of depression or anxiety; this finding could explain the lack of effects of placebo supplementation in reducing both the scores.…”

Anxiety and Depressive Disorders in Older Primary Care Patients: Defining a Clinical Severity Gradient Corresponding to Differences in Health Status, Functioning, and Health Service Use

“…This finding is consistent with general population studies such as the National Comorbidity Survey in which 62% of patients with a lifetime diagnosis of generalized anxiety disorder had a major depressive disorder and 40% had dysthymia (Wittchen et al 1994). Other studies have reported that the prevalence of depression occurring in anxiety disorders in older adults ranges from 70-90% (Lindesay et al 1989;Manela et al 1996). Depression in older persons is less likely to be treated when it occurs in the context of significant symptoms of anxiety and is more likely to be inappropriately treated with benzodiazepines (Flint 1998;Bartels et al 1997).…”